Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2013
11/27/2013CN102633786B Iloperidone pharmaceutical cocrystal and preparation method thereof
11/27/2013CN101977900B 5-fluoro pyrimidine derivatives
11/27/2013CN101918362B 吡啶衍生物 Pyridine derivatives
11/26/2013US8592470 Sitaxentan derivative
11/26/2013US8592464 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
11/26/2013US8592460 Amino-pyridine derivatives as S1P1 /EDG1 receptor agonists
11/26/2013US8592418 5-aryl isoxazolines for controlling pests
11/26/2013US8592417 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhibitors
11/26/2013US8592413 Therapeutic substituted cyclopentanes
11/26/2013US8592410 Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
11/26/2013US8592383 Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulators
11/26/2013CA2759399C Inhibitors of the renal outer medullary potassium channel
11/26/2013CA2335240C Cyanine dyes and synthesis methods thereof
11/21/2013WO2013173382A1 Benzothiophene sulfonamides and other compounds that interact with glucokinase regulatory protein
11/21/2013WO2013173218A1 1,3-diaryl-substituted heterocyclic pesticides
11/21/2013WO2013172255A1 Compound, light emitting material, and organic light emitting element
11/21/2013WO2013171642A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171640A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171318A1 Benzo[1,3]dioxine derivatives and their use as lpar5 antagonists
11/21/2013WO2013171281A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/21/2013US20130310427 Inhibitors of hcv ns5a protein
11/21/2013US20130310380 Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer's disease
11/21/2013US20130310378 4-(4-pyridinyl)-benzamides and their use as rock activity modulators
11/21/2013US20130310377 Novel modulators of calcium release-activated calcium channel
11/21/2013US20130310365 Cyclohexyl-azetidinyl antagonists of ccr2
11/21/2013US20130310364 Compositions and methods for inhibition of the jak pathway
11/21/2013US20130310361 Compounds and compositions as kinase inhibitors
11/21/2013US20130310358 Pyrimidine compounds as delta opioid receptor modulators
11/21/2013US20130310357 Azolyl Urea Compounds and Methods of Use Thereof
11/21/2013US20130310347 Multi-modality molecular imaging high-throughput assay for identifying heat shock protein 90 (hsp90) inhibitors
11/21/2013US20130310344 N-acylsulfonamide apoptosis promoters
11/21/2013US20130309272 Compounds for inflammation and immune-related uses
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2663562A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
11/20/2013EP2663561A1 Novel heterocyclic derivatives and their use in the treatment of neurological disorders
11/20/2013EP2663560A1 Crystalline oxazine derivative and its use as bace inhibitor
11/20/2013EP2663559A1 Oxazine derivatives and their use in the treatment of neurological disorders
11/20/2013EP2663553A2 Quinoline and isoquinoline compounds and methods of use thereof
11/20/2013EP2663551A1 New fluorescent compounds
11/20/2013EP2663550A2 Substituted benzoazepines as toll-like receptor modulators
11/20/2013EP2514750B1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
11/20/2013EP2407451B1 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/20/2013EP2403832B1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
11/20/2013EP2271621B1 Pyridyl derivatives as cftr modulators
11/20/2013EP2246338B1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/20/2013EP2091943B1 Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors
11/20/2013EP2007747B1 Process for preparing heterocyclic derivatives
11/20/2013EP1801108B9 Morpholine compounds for the treatment of inflammations
11/20/2013EP1765805B1 Cgrp receptor antagonists
11/20/2013EP1709044B2 Oxazolidinone-quinolone hybrid antibiotics
11/20/2013CN103403001A Novel heterocyclic derivatives and their use in the treatment of neurological disorders
11/20/2013CN103403000A Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
11/20/2013CN103402999A Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
11/20/2013CN103402987A 6-amino-2-phenylamino-1H-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin E2 synthase-1 inhibitors
11/20/2013CN103402984A Novel kinase inhibitors
11/20/2013CN103402983A (Pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 NACHR
11/20/2013CN103402515A Sgc stimulators
11/20/2013CN103402511A Novel benzodioxole piperidine compounds
11/20/2013CN103396413A Preparation method of nifuratel
11/20/2013CN103396412A Modifier of 5-HT2A serotonin receptor
11/20/2013CN103396411A Quinoxaline derivative, and light-emitting element and electronic device using same
11/20/2013CN103396410A Synthesis of pyridine famoxadone and its application as agricultural fungicide
11/20/2013CN103396409A Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
11/20/2013CN103396402A Substituted aminoindanes and analogs thereof, and pharmaceutical use thereof
11/20/2013CN102471294B Chiral cyclic beta-amino aryl butyric acid derivatives, their preparation methods and methods for preparation of chiral beta-amino aryl butyric acid derivatives via them
11/20/2013CN102056922B Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIA
11/19/2013US8586747 3,3-dimethyl tetrahydroquinoline derivatives
11/19/2013US8586737 Process of a quaternary ammonium salt using phosphate
11/19/2013US8586599 Polymorphic forms of 6-(1-methyl-1H-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2H-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof
11/19/2013US8586590 Compounds
11/19/2013US8586583 Compounds
11/19/2013US8586582 PI3K/mTOR kinase inhibitors
11/19/2013US8586571 Heterocyclic compound
11/19/2013US8586082 Solid orally administerable pharmaceutical dosage forms with rapid active principle release
11/19/2013CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
11/19/2013CA2707418C Inhibitors of human immunodeficiency virus replication
11/19/2013CA2633624C 3,5-substituted piperidine compounds as renin inhibitors
11/19/2013CA2618340C Piperidine and piperazine derivatives as p2x3 antagonists
11/19/2013CA2558848C Isoxazoline-substituted benzamide compound and pesticide
11/14/2013WO2013170186A1 Carbazole-containing sulfonamides as cryptochrome modulators
11/14/2013WO2013170113A1 Nampt inhibitors
11/14/2013WO2013169622A1 Azetidine derivatives as antiparasitic agents
11/14/2013WO2013167495A1 Bicyclically substituted uracils and the use thereof
11/14/2013WO2013167295A1 (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel
11/14/2013US20130303540 5-methyl-1-(naphthalen-2-yl)-1h-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
11/14/2013US20130303525 Kappa opioid receptor agonists
11/14/2013US20130303522 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
11/14/2013US20130303516 Novel triazine compounds
11/14/2013US20130303515 Novel compounds useful for the treatment of metabolic and inflammatory diseases
11/14/2013US20130303514 2-methoxy-pyridin-4-yl-derivatives
11/14/2013US20130303513 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
11/14/2013US20130303507 Substituted hetero-biaryl compounds and their uses
11/14/2013US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase
11/14/2013US20130303492 3,5-diaminopyrazole kinase inhibitors
11/14/2013US20130302378 Matrix metalloproteinase inhibitors
11/13/2013EP2662371A1 (R)-Nifuratel and synthesis of (R) and (S)-Nifuratel
11/13/2013EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators
11/13/2013EP2662357A1 Novel bicyclic compound or salt thereof
11/13/2013EP2662353A2 Antibacterial agents
11/13/2013EP2661434A1 Novel ureas for the treatment and prevention of cancer
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 647